Growth Metrics

Whitehawk Therapeutics (WHWK) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 66.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 137.65%
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn - -78.88%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -78.88%
Dec 31, 2025 -20.68%
Sep 30, 2025 7.16%
Jun 30, 2025 -481.71%
Mar 31, 2025 39.12%
Dec 31, 2024 -9.22%
Sep 30, 2024 -65.39%
Jun 30, 2024 51.12%
Mar 31, 2024 6.01%
Dec 31, 2023 -18.49%
Sep 30, 2023 -17.69%
Jun 30, 2023 -71.46%
Mar 31, 2023 -11.62%
Dec 31, 2022 8.37%
Sep 30, 2022 51.02%
Jun 30, 2022 -237.46%
Mar 31, 2022 -284.02%
Dec 31, 2021 -279.48%
Sep 30, 2021 -10.06%
Jun 30, 2021 -130.95%
Mar 31, 2021 368.11%
Dec 31, 2020 32.68%
Sep 30, 2020 -231.10%
Jun 30, 2020 295.46%
Mar 31, 2020 57.14%
Dec 31, 2019 21.45%
Sep 30, 2019 23.63%
Jun 30, 2019 -140.16%
Mar 31, 2019 -40.92%
Dec 31, 2018 -34.21%
Sep 30, 2018 -55.33%
Jun 30, 2018 307.24%
Mar 31, 2018 -65.91%
Dec 31, 2017 -51.71%
Sep 30, 2017 16.81%
Jun 30, 2017 -59.17%
Mar 31, 2017 1.31%
Dec 31, 2016 -110,876.32%
Sep 30, 2016 -126,199.01%
Jun 30, 2016 -30,032.41%
Mar 31, 2016 -201,497.98%
Dec 31, 2015 78.25%
Sep 30, 2015 -124.87%
Jun 30, 2015 -903.19%
Mar 31, 2015 -394.00%
Dec 31, 2014 -214.16%
Sep 30, 2014 79.06%
Jun 30, 2014 85.84%
Mar 31, 2014 78.96%
Dec 31, 2013 -411.73%
Sep 30, 2013 -107.27%
Jun 30, 2013 35.00%
Mar 31, 2013 65.61%
Dec 31, 2012 60.90%
Sep 30, 2012 -26.45%
Jun 30, 2012 7.25%
Mar 31, 2012 -144.13%
Dec 31, 2011 -463.20%
Sep 30, 2011 11.58%